University of Thessaly
uth.grTotal trials
187
Active
42
Phase 3
1
Total enrollment
29,668
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tapentadol | — | — | — | — | — | 1 | |
| Tramadol | — | — | — | — | — | 1 | |
| Gemcitabine Hydrochloride combined with continuous saline irrigation | — | — | — | — | — | 1 | |
| Epirubicin Hydrochloride combined with continuous saline irrigation | — | — | — | — | — | 1 | |
| ultra early physiotherapy intervention | — | — | — | — | — | 1 |
Next readouts
- 2025-05-01
- 2025-10
- 2025-10-30
Top conditions
- Body Composition9
- Oxidative Stress8
- Skeletal Muscle Damage7
- Muscle Damage6
- Energy Expenditure6
- Resting Metabolic Rate6
- Chronic Pain5
- Chronic Musculoskeletal Pain5
Frequently asked questions about University of Thessaly
- How many clinical trials does University of Thessaly have on ClinicalTrials.gov?
- University of Thessaly is listed as the lead sponsor on 187 clinical trials in ClinicalTrials.gov, 42 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Thessaly's trials are in Phase 3?
- 1 of University of Thessaly's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does University of Thessaly focus on?
- University of Thessaly's most-studied conditions on ClinicalTrials.gov are Body Composition, Oxidative Stress, Skeletal Muscle Damage, Muscle Damage, Energy Expenditure.
- When are University of Thessaly's next clinical trial readouts?
- University of Thessaly has 3 upcoming primary-completion readouts tracked here; the soonest is “Tapentadol vs Tramadol in Total Knee Arthroplasty”, expected around 2025-05-01.